Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Clinical Features of Pediatric Acute Myeloid Leukemia with TP53 and CDKN2A / 2B copy Number Alterations

Blood (2019) 134 (Supplement_1): 2727.

https://doi.org/10.1182/blood-2019-126263

Published: 2019

Journal Articles

Leukemic Cell with a Novel Kinase Fusion Gene SPAG9-JAK2 Exhibits High Sensitivity to Ruxolitinib

Azusa Mayumi, MD, Toshihiro Tomii, MD, Toshihiko Imamura, MD PhD, Machiko Kawamura, MD, Hajime Hosoi, MD PhD

Blood (2019) 134 (Supplement_1): 5044.

https://doi.org/10.1182/blood-2019-126592

Published: 2019

Journal Articles

Identification of the Novel Fusion Gene, SPAG9-JAK2 , in Adolescent Acute Lymphoblastic Leukemia (ALL) with t(9;17)(p24;q21), and Its Association with Gene Alterations Involved in Ph1/ BCR-ABL1 -like ALL

Machiko Kawamura, MD PhD, Tomohiko Taki, MD PhD, Kentarou Ohki, MD, Yasuhide Hayashi, MD PhD

Blood (2014) 124 (21): 5356.

https://doi.org/10.1182/blood.V124.21.5356.5356

Published: 2014

Journal Articles

Low-Dose Cytosine Arabinoside Therapy for Neonates with Down Syndrome (DS) and Transient Leukemia (TL).

Hideki Muramatsu, MD, PhD, Yasuhide Hayashi, MD, PhD, Machiko Kawamura, MD, PhD, Seiji Kojima, MD, PhD, Miharu Yabe, Keiichi Isoyama, Tomohiko Taki, MD, PhD, Kohichiro Tsuji, MD, PhD, Masahiro Tsuchida, MD, PhD, Atsushi Manabe, Etsuro Ito, MD, PhD, Shotaro Iwamoto, MD, PhD, Hiromi Kato, Aiko Sumie, Takashi Taga, MD, PhD, Keiko Nomura, Daisuke Hasegawa, MD, PhD, Ken-ichiro Watanabe, Akira Kikuchi

Blood (2010) 116 (21): 1074.

https://doi.org/10.1182/blood.V116.21.1074.1074

Published: 2010

Journal Articles

Molecular Monitoring of ERG and BAALC as Minimal Residual Disease Markers in Patients with Acute Leukemia.

Yuho Najima, MD, Kazuteru Ohashi, MD,FACP, Kazuhiko Kakihana, MD,PhD, Taku Kikuchi, MD, Yasunobu Nagata, MD, Chihiro Sakurai, MD, Toshimitsu Ueki, MD, Takeshi Kobayashi, MD, Takuya Yamashita, MD, Machiko Kawamura, MD,PhD, Hideki Akiyama, MD,PhD, Hidefumi Kaku, MD,PhD, Hisashi Sakamaki, MD,PhD

Blood (2007) 110 (11): 4249.

https://doi.org/10.1182/blood.V110.11.4249.4249

Published: 2007

NARROW

Clinical Features of Pediatric Acute Myeloid Leukemia with TP53 and CDKN2A / 2B copy Number Alterations

Leukemic Cell with a Novel Kinase Fusion Gene SPAG9-JAK2 Exhibits High Sensitivity to Ruxolitinib

Identification of the Novel Fusion Gene, SPAG9-JAK2 , in Adolescent Acute Lymphoblastic Leukemia (ALL) with t(9;17)(p24;q21), and Its Association with Gene Alterations Involved in Ph1/ BCR-ABL1 -like ALL

Low-Dose Cytosine Arabinoside Therapy for Neonates with Down Syndrome (DS) and Transient Leukemia (TL).

Molecular Monitoring of ERG and BAALC as Minimal Residual Disease Markers in Patients with Acute Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Clinical Features of Pediatric Acute Myeloid Leukemia with TP53 and CDKN2A / 2B copy Number Alterations

Leukemic Cell with a Novel Kinase Fusion Gene SPAG9-JAK2 Exhibits High Sensitivity to Ruxolitinib

Identification of the Novel Fusion Gene, SPAG9-JAK2 , in Adolescent Acute Lymphoblastic Leukemia (ALL) with t(9;17)(p24;q21), and Its Association with Gene Alterations Involved in Ph1/ BCR-ABL1 -like ALL

Low-Dose Cytosine Arabinoside Therapy for Neonates with Down Syndrome (DS) and Transient Leukemia (TL).

Molecular Monitoring of ERG and BAALC as Minimal Residual Disease Markers in Patients with Acute Leukemia.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only